Abstract
Targeted nanoparticulated drug delivery systems have gained much attention owing to their potential in elevating anti-tumor effect and decreasing drug-originated side effects. In this contribution, a kind of dual glioma targeting delivery system was developed through co-modification nanoparticles with interlukin-13 peptide (IL-13p) and RGD peptide (IRNPs), in which IL-13p could target to IL13Rα2 on tumor cells and RGD could target to αvβ3 on neovasculature. The model drug, docetaxel (DTX), could release from the unmodified nanoparticles (NPs) and IRNPs at a sustained manner. In vitro, the uptake of IRNPs by C6 (a glioma cell line) cells was time- and concentration-dependent, which was significantly higher than the uptake of NPs and single modified nanoparticles. After loading with DTX, IRNPs induced the highest percentage of apoptotic cells. In vivo, DTX-loaded IRNPs induced obviously higher apoptosis of cells in glioma site. These results indicated the dual modification could improve the cellular uptake as well as antitumor effect, which demonstrated IRNPs were promising drug delivery systems for glioma targeting treatment.
Keywords: Dual targeting, glioma, interleukin 13 peptide, nanoparticles, RGD.
Current Pharmaceutical Biotechnology
Title:Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles
Volume: 14 Issue: 13
Author(s): Huile Gao, Yue Hu, Yang Xiong, Shuang Zhang, Jiarong Yang, Lian Yu and Xinguo Jiang
Affiliation:
Keywords: Dual targeting, glioma, interleukin 13 peptide, nanoparticles, RGD.
Abstract: Targeted nanoparticulated drug delivery systems have gained much attention owing to their potential in elevating anti-tumor effect and decreasing drug-originated side effects. In this contribution, a kind of dual glioma targeting delivery system was developed through co-modification nanoparticles with interlukin-13 peptide (IL-13p) and RGD peptide (IRNPs), in which IL-13p could target to IL13Rα2 on tumor cells and RGD could target to αvβ3 on neovasculature. The model drug, docetaxel (DTX), could release from the unmodified nanoparticles (NPs) and IRNPs at a sustained manner. In vitro, the uptake of IRNPs by C6 (a glioma cell line) cells was time- and concentration-dependent, which was significantly higher than the uptake of NPs and single modified nanoparticles. After loading with DTX, IRNPs induced the highest percentage of apoptotic cells. In vivo, DTX-loaded IRNPs induced obviously higher apoptosis of cells in glioma site. These results indicated the dual modification could improve the cellular uptake as well as antitumor effect, which demonstrated IRNPs were promising drug delivery systems for glioma targeting treatment.
Export Options
About this article
Cite this article as:
Gao Huile, Hu Yue, Xiong Yang, Zhang Shuang, Yang Jiarong, Yu Lian and Jiang Xinguo, Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles, Current Pharmaceutical Biotechnology 2013; 14 (13) . https://dx.doi.org/10.2174/1389201015666140425102937
DOI https://dx.doi.org/10.2174/1389201015666140425102937 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Anti-Cancer Agents in Medicinal Chemistry Carbonic Anhydrase Inhibitors as Anticonvulsant Agents
Current Topics in Medicinal Chemistry Computational Studies on Translocator Protein (TSPO) and its Ligands
Current Topics in Medicinal Chemistry Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Estrogen Regulation of MicroRNA Expression
Current Genomics Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma
Current Pharmaceutical Design C-Glycosides and Aza-C-Glycosides as Potential Glycosidase and Glycosyltransferase Inhibitors
Current Topics in Medicinal Chemistry HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy
Current Medicinal Chemistry Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design Targeting Focal Adhesion Kinase in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Regulatory T Cells: Major Players in the Tumor Microenvironment
Current Pharmaceutical Design HIF Prolyl 4-Hydroxylases and their Potential as Drug Targets
Current Pharmaceutical Design Targeting Poly (ADP) Ribose Polymerase I (PARP-1) and PARP-1 Interacting Proteins for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design MicroRNAs Patents: The Road From Bench to Bedsides for Cancer Treatment
Recent Patents on DNA & Gene Sequences Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
Current Cancer Drug Targets Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Synthesis of Prenylated Xanthones: An Overview
Current Organic Chemistry In vivo Fluorescence Detection in Surgery: A Review of Principles, Methods, and Clinical Applications
Current Medical Imaging CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets